Mereo Biopharma Group Plc - ADR Live Stock Price Today, Share Analysis and Chart

Name: Mereo Biopharma Group Plc - ADR: Is Infosys Ltd. worth buying?
Item: Mereo Biopharma Group Plc - ADR
Rating: 0.83850
Author: Trendlyne DVM scores

about

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disea...

1.53 -0.05 (-3.16%)

New 52W Low today

1.5M

XNAS Volume

XNAS 08 Aug, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Mereo Biopharma Group Plc - ADR is on 13 Aug 2025 for the purpose of Mereo BioPharma Group PLC Second Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

5.0 / 100

Technically Bearish

28.5 / 100

1Yr Price target upside is 392%

8 analysts

Mereo Biopharma Group Plc ... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Mereo Biopharma Group Plc - ADR Live Stock Price Today, Share Analysis and Chart

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disea...

New 52W Low today

SWOT Analysis

Mereo Biopharma Group Plc ... Live Price Chart